Cargando…

Is combined lipid-regulating therapy safe and feasible for the very old patients with mixed dyslipidemia?

OBJECTIVES: To detect the efficacy and safety of combined lipid-regulating therapies in the very old patients with mixed dyslipidemia and determine an appropriate therapy for them. METHODS: Four hundred and fifty patients aged over 75 with mixed dyslipidemia were divided into five groups according t...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zou, Xiao, Si, Quan-Jin
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Science Press 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3888917/ https://www.ncbi.nlm.nih.gov/pubmed/24454328 http://dx.doi.org/10.3969/j.issn.1671-5411.2013.04.014

Ejemplares similares

Is cardiac resynchronisation therapy feasible, safe and beneficial in the very elderly?
por: Olechowski, Bartosz, et al.
Publicado: (2015)

Fenofibrate/simvastatin fixed-dose combination in the treatment of mixed dyslipidemia: safety, efficacy, and place in therapy
por: Tarantino, Nicola, et al.
Publicado: (2017)

Long-Term Use of Temozolomide as Safe and Effective Therapy for an Aggressive Corticotroph Adenoma in a Very Old Patient
por: Decaroli, Maria Chiara, et al.
Publicado: (2021)

Feasibility of Lipid Screening During First Trimester of Pregnancy to Identify Women at Risk of Severe Dyslipidemia
por: Golwala, Sohil, et al.
Publicado: (2023)

Real-World Effectiveness of Therapy With Rosuvastatin Combined With Fenofibric Acid in a Sample of Colombian Patients With Mixed Dyslipidemia
por: Machado-Duque, Manuel E., et al.
Publicado: (2020)

Effects of rosuvastatin combined with fasudil therapy on rabbits with dyslipidemia
por: Li, Zhiming, et al.
Publicado: (2015)

Combination Therapy of Ezetimibe and Rosuvastatin for Dyslipidemia: Current Insights
por: Chilbert, Maya R, et al.
Publicado: (2022)

Serum lipids and associated factors of dyslipidemia in the adult population in Shenzhen
por: Ni, Wen-Qing, et al.
Publicado: (2015)

Association Between the Awareness of Dyslipidemia and Health Behavior for Control of Lipid Levels Among Korean Adults with Dyslipidemia
por: Cho, In Young, et al.
Publicado: (2017)

Mixed dyslipidemias in primary care patients in France
por: Laforest, Laurent, et al.
Publicado: (2012)

Vitamin D level regulates serum lipids discrepantly in adults with and without dyslipidemia
por: Cheng, Ying-Lien, et al.
Publicado: (2023)

Effect of Abdominoplasty in the Lipid Profile of Patients with Dyslipidemia
por: Ramos-Gallardo, Guillermo, et al.
Publicado: (2013)

Dietary Lipids and Dyslipidemia in Chronic Kidney Disease
por: Kochan, Zdzislaw, et al.
Publicado: (2021)

Lipid-Lowering Nutraceuticals for an Integrative Approach to Dyslipidemia
por: Cheung, Brian, et al.
Publicado: (2023)

Statin therapy/lipid lowering therapy among Indian adults with first acute coronary event: The dyslipidemia Residual and Mixed Abnormalities IN spite of Statin therapy (REMAINS) study
por: Jaywant, Salgaonkar V., et al.
Publicado: (2016)

Characterization of lipoprotein profiles in patients with hypertriglyceridemic Fredrickson-Levy and Lees dyslipidemia phenotypes: the Very Large Database of Lipids Studies 6 and 7
por: Quispe, Renato, et al.
Publicado: (2019)

Modern prevalence of the Fredrickson-Levy-Lees dyslipidemias: findings from the Very Large Database of Lipids and National Health and Nutrition Examination Survey
por: Sathiyakumar, Vasanth, et al.
Publicado: (2019)

Safety and efficacy of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Viljoen, Adie, et al.
Publicado: (2010)

Critical appraisal of laropiprant and extended-release niacin combination in the management of mixed dyslipidemias and primary hypercholesterolemia
por: Hussein, Ayman A, et al.
Publicado: (2010)

Fenofibric acid: a new fibrate approved for use in combination with statin for the treatment of mixed dyslipidemia
por: Alagona, Peter
Publicado: (2010)

Review of extended-release niacin/laropiprant fixed combination in the treatment of mixed dyslipidemia and primary hypercholesterolemia
por: Parhofer, Klaus G
Publicado: (2009)

Efficacy of Statin Monotherapy or in Combination With Coenzyme A Capsule in Patients With Metabolic Syndrome and Mixed Dyslipidemia
por: Lai, Jiangtao, et al.
Publicado: (2015)

Prevalence of lipid abnormalities before and after introduction of lipid modifying therapy among Swedish patients with dyslipidemia (PRIMULA)
por: Pettersson, Billie, et al.
Publicado: (2010)

Laparoscopic removal of a very large uterus weighting 5320 g is feasible and safe: a case report
por: Macciò, Antonio, et al.
Publicado: (2017)

Statin Therapy in Very Old Patients: Lights and Shadows
por: Cobos-Palacios, Lidia, et al.
Publicado: (2021)

Nutrition in the Very Old
por: Granic, Antoneta, et al.
Publicado: (2018)

Dyslipidemia in subclinical hypothyroidism and the effect of thyroxine on lipid profile
por: Asranna, Ajay, et al.
Publicado: (2012)

Clinical considerations of lipid target and goal in dyslipidemia control
por: Wu, Na-Qiong, et al.
Publicado: (2016)

Nonfasting Lipid Profile May Suffice to Manage Dyslipidemia
por: Andrade, Chittaranjan
Publicado: (2020)

The Effect of BMI on Blood Lipids and Dyslipidemia in Lactating Women
por: Yu, Lianlong, et al.
Publicado: (2022)

Paracetamol preceding very preterm birth: Is it safe?
por: Laitala, Aliisa, et al.
Publicado: (2022)

Is it Time for Single-Pill Combinations in Dyslipidemia?
por: Schiele, François, et al.
Publicado: (2021)

Hypertension and Dyslipidemia Combined Therapeutic Approaches
por: Borghi, Claudio, et al.
Publicado: (2022)

Treatment of dyslipidemia in the elderly
por: Shao, Hong, et al.
Publicado: (2011)

Rezum therapy, a feasible and safe treatment for the larger prostate
por: Rowaiee, Rashed, et al.
Publicado: (2021)

Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
por: Hershlag, Avner, et al.
Publicado: (2018)

Is Fertility Preservation Feasible and Safe With Neoadjuvant Therapy for Breast Cancer?
por: Hershlag, Avner, et al.
Publicado: (2020)

Alirocumab vs usual lipid‐lowering care as add‐on to statin therapy in individuals with type 2 diabetes and mixed dyslipidaemia: The ODYSSEY DM‐DYSLIPIDEMIA randomized trial
por: Ray, Kausik K., et al.
Publicado: (2018)

Linking Emotion Regulation Capacity and the Frequency of Daily Stressors in Old and Very Old Age
por: Katzorreck, Martin, et al.
Publicado: (2021)

Clinical outcomes and mortality in old and very old patients undergoing cardiac resynchronization therapy
por: Montenegro Camanho, Luiz Eduardo, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_elh8gp1ncdof43d893lp7rkg1n